Physician profile
Jerry Caporaso
NPI 1578532875
$9,865.36
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,217 · 2020: $996 · 2021: $1,211 · 2022: $2,190 · 2023: $435 · 2024: $3,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $651 · Travel and Lodging: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $651.40 |
| Travel and Lodging | $600.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,816.68 | 2024 | |
| Abbvie INC. | $1,062.73 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Pfizer INC. | $793.79 | 2019-2023 | |
| Therapeuticsmd, INC. | $596.87 | 2019-2022 | |
| Amgen INC. | $450.30 | 2019-2023 | Evenity, Prolia |
| Scynexis, INC. | $324.46 | 2022 | |
| Mayne Pharma Commercial LLC | $315.88 | 2021-2023 | |
| Urovant Sciences INC | $288.93 | 2021-2022 | |
| Astellas Pharma US INC | $281.56 | 2019-2023 | Myrbetriq |
| Myovant Sciences INC. | $277.67 | 2021-2022 | |
| Radius Health, INC. | $265.28 | 2019-2023 | |
| Lupin INC. | $223.53 | 2019-2020 | |
| Exeltis, USA INC. | $175.41 | 2019-2022 | |
| Avion Pharmaceuticals | $102.84 | 2020-2022 | |
| Hologic Sales and Service, LLC | $90.40 | 2020-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $79.50 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $76.04 | 2023 | Gemtesa, Myfembree |
| Teleflex LLC | $75.40 | 2019 | |
| Allergan, INC. | $74.01 | 2019-2020 | |
| Agile Therapeutics, INC. | $57.32 | 2021-2022 | |
| Caldera Medical, INC | $49.03 | 2022 | |
| Coopersurgical, INC. | $46.86 | 2019-2022 | |
| Exact Sciences Corporation | $36.87 | 2023 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $36.39 | 2019 | |
| Mylan Pharmaceuticals INC. | $35.67 | 2020-2021 | |
| Boston Scientific Corporation | $28.98 | 2019 | |
| Duchesnay USA Incorporated | $28.72 | 2019 | |
| Amag Pharmaceuticals, INC. | $28.05 | 2019 | |
| Daiichi Sankyo INC. | $24.34 | 2022 | |
| Astellas Pharma Global Development | $22.00 | 2023 | Veozah |
| Alvogen INC | $19.49 | 2022 | |
| Virtus Pharmaceuticals LLC | $18.29 | 2021 | |
| Merck Sharp & Dohme LLC | $18.14 | 2020 | |
| Millicent US INC | $16.48 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.49 | 2022 | |
| Ethicon US, LLC | $12.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Caporaso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.